Radiosynthesis of bromine-76 and iodine-123 labelled enantiomers of A-69024: Radioligands for dopamine D1 receptor studies using PET and SPECT

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 43, Issue 4, 2000, Pages 339-346

  Kassiou, Michael ^a   Loc'h, Christian ^b   Katsifis, Andrew ^c   Papazian, Vahan ^c   Mattner, Filomena ^c   Dikic, Branko ^c   Mazière, Bernard ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c PMB 1 Menai   (Australia)

Author keywords

A 69024; Bromine 76; Dopamine D1 receptors; Iodine 123; PET; SPECT

Indexed keywords

AMINES; BROMINE; IODINE; NEUROPHYSIOLOGY; STEREOCHEMISTRY;

A-69024; BROMINE-76; CHIRAL HPLC; DOPAMINE; DOPAMINE D1 RECEPTOR; IODINE-123; RADIOCHEMICAL YIELD; RADIOLIGANDS; SPECIFIC ACTIVITY; SPECT;

ENANTIOMERS;

1 (2 BROMO 4,5 DIMETHOXYBENZYL) 1,2,3,4 TETRAHYDRO 7 HYDROXY 6 METHOXY 2 METHYLISOQUINOLINE; BROMINE; BROMINE 76; DOPAMINE 1 RECEPTOR; IODINE 123; RADIOLIGAND; SODIUM; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG;

ARTICLE; CHIRAL CHROMATOGRAPHY; DRUG LABELING; DRUG PURITY; ENANTIOMER; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THIN LAYER CHROMATOGRAPHY;

EID: 0034732340     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(20000330)43:4<339::AID-JLCR321>3.0.CO;2-6     Document Type: Article

References (20)

1. Jackson D. M. and Westlind-Danielsson A. Pharmac. Ther. 64: 291-370 (1994)
2. Sibley D. R. and Monsa F. J. Trends Pharmacol. Sci. 13: 61-59 (1992)
3. Halldin C., Stone-Elander S., Farde L. Ehrin E., Fasth K.-J., Langstrom B. and Sedvall G. Appl. Radiat. Isot. 37: 1039-1043 (1986)
4. Raven H. T., Wilson A. A., Dannals R. F., Wong D. F. and Wagner H. N. Jr. Appl. Radiat. Isot. 38: 305-306 (1987)
5. Hall H., Farde L. and Sedvall G. J. Neural Trans. 73: 7-21 (1988)
6. Nicklaus K. J., McGonigle P., Molinoff P. B. J. Pharmacol. Exp. Ther. 247: 343-348 (1988)
7. McQuade R. D., Chipkin R., Amlaiky N., Caron M., Iorio L. and Barnett A. Life Sci. 43: 1151-1160 (1988)
8. Billings J. J., Kung M. P., Chumpradit S., Pan S., Kung H. F. Life Sci. 45: 711-718 (1989)
9. Chumpradit S., Kung M. P., Billings J. J., Kung H. F. J. Med. Chem. 34: 877-883 (1991)
10. Halldin C., Farde L., Barnett A. and Sedvall G. Appl. Radiat. Isot. 42: 451-455 (1991)
11. Sedvall G., Farde L., Barnett A., Hall H., Halldin C. Psychopharmacol. 103: 150-153 (1991)
12. Halldin C., Foged C., Farde L., Karlsson P., Hall H., Hansen., Gronvald F. C., Swahn C.-G. and Sedvall G. Nucl. Med. Biol. 20: 945-953 (1993)
13. Karlsson P., Farde L., Halldin C., Swahn C-G., Sedvall G., Foged C. and Skrumsager B. Psychopharmacol. 113: 149-156 (1993)
14. Foged C., Halldin C., Loc'h C., Mazière B., Karlsson P., Mazière M., Swahn C-G. and Farde L. Nucl. Med. Biol. 23: 837-844 (1996)
15. Kerkman D. J., Ackerman M., Artman L. D., MacKenzie R. G., Johnson M. C., Bednarz L., Montana W., Asin K. E., Stampfli H., Kebabian J. Eur. J. Pharmacol. 166: 481-491 (1989)
16. Kassiou M., Mathews W. B., Musachio J. L., Ravert H. T., Lambrecht R. M. and Dannals R. F. J. Labelled Cpds. Radiopharm. 34: 431-437 (1994)
17. Kassiou M., Scheffel U., Ravert H. T., Mathews W. B., Musachio J. L., Lambrecht R. M. and Dannals R. F. Nucl. Med. Biol. 22: 221-2226 (1995)
18. Kametani T. and Ogasawara K. - J. Chem. Soc. (C). 2208-2212 (1967)
19. Loc'h C., Mardon K., Valette H., Brustesco C., Merlet P., Syrota A. and Maziere B. Nucl. Med. Biol. 21: 49-55 (1994)
20. Weisgraber K. H. and Weiss U. J.Chem.Soc. Perkin I. 83-38 (1972)